ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

Novartis India to acquire Pfizer's 'Minipress' trademark for Rs 1,250 crore
Novartis India will acquire the Minipress and Minipres trademarks and related intellectual property from Pfizer for about ?1,250 crore. Minipress XL, used for hypertension and benign prostatic hyperplasia, generated ?228.6 crore in revenue as of July 2026,
Announcement as on 07 September 2026

Novartis India eyes therapy-aligned acquisition, Tier 2-3 market push
Pharma company Novartis India Ltd (NIL) plans to pursue disciplined, therapy-aligned acquisitions and deepen its last-mile reach into Tier 2 and Tier 3 markets to drive its next phase of growth, according to the company's annual report. The company's futur
Announcement as on 06 September 2026

ChrysCapital acquires controlling 70.68% stake in Novartis' India listed unit in first majority pharma investment
ChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical landscape. Following this acquisition, the company is set to unveil a fresh name and corporate identity. Vikas Gupta
Announcement as on 30 July 2026

Novartis India launches Pluvicto for prostate cancer treatment
Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision radiotherapy precisely targets cancer cells, offering a new treatment approach for metastatic prostate cancer. The t
Announcement as on 15 June 2026

India needs to remain attractive for innovation-led investment: Judith Love, Novartis
With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The company underscores the importance of collaboration to tackle obstacles like high costs and inadequate infrastructure.
Announcement as on 12 June 2026

Announcements by Novartis first page | Next page | Prev page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 1997.11
  • 12Day Average: 1982.7
  • 20Day Average: 2047.34
  • 50Day Average: 1759.94
  • 100Day Average: 1600.69
  • 150Day Average: 1397.75
  • 200Day Average: 1249.88

500672 Indicators & signals

Indicator MACD (12,26,9)

1987.22, 1922.73, 83.21
Indicator MACD is in positive zone

Indicator ADX (14)

34.31, 31.49, 15.4
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 66
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Tue Oct 2026 1988.60 1939.95 to 2037.95 -1.23% 0.45 times
12 Mon Oct 2026 2013.35 2001.00 to 2101.85 -1.74% 0.24 times
06 Tue Oct 2026 2049.05 1942.15 to 2072.75 4.19% 0.94 times
05 Mon Oct 2026 1966.70 1961.65 to 2164.60 -0.06% 3.31 times
01 Thu Oct 2026 1967.85 1900.00 to 1979.95 1.78% 0.84 times
29 Tue Sep 2026 1933.35 1903.75 to 1977.90 -0.1% 0.53 times
28 Mon Sep 2026 1935.30 1925.70 to 2026.75 -1.33% 0.77 times
25 Fri Sep 2026 1961.40 1939.00 to 1979.95 -0.46% 0.38 times
24 Thu Sep 2026 1970.55 1960.00 to 2028.00 -2.78% 0.57 times
23 Wed Sep 2026 2026.85 1962.70 to 2096.30 2.54% 1.12 times
22 Tue Sep 2026 1976.65 1967.00 to 2045.35 -1.3% 1.32 times
21 Mon Sep 2026 2002.75 1989.20 to 2066.00 -2.66% 1.27 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top